HK1006024A1 - Hirudin derivatives with delayed action - Google Patents

Hirudin derivatives with delayed action

Info

Publication number
HK1006024A1
HK1006024A1 HK98105201A HK98105201A HK1006024A1 HK 1006024 A1 HK1006024 A1 HK 1006024A1 HK 98105201 A HK98105201 A HK 98105201A HK 98105201 A HK98105201 A HK 98105201A HK 1006024 A1 HK1006024 A1 HK 1006024A1
Authority
HK
Hong Kong
Prior art keywords
delayed action
hirudin derivatives
hirudin
derivatives
delayed
Prior art date
Application number
HK98105201A
Other languages
English (en)
Inventor
Peter Crause
Paul Habermann
Martin Kramer
Rainer Obermeier
Klaus Sauber
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6355879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006024(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HK1006024A1 publication Critical patent/HK1006024A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK98105201A 1988-06-04 1998-06-11 Hirudin derivatives with delayed action HK1006024A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819079A DE3819079A1 (de) 1988-06-04 1988-06-04 Hirudin-derivate mit verzoegerter wirkung

Publications (1)

Publication Number Publication Date
HK1006024A1 true HK1006024A1 (en) 1999-02-05

Family

ID=6355879

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105201A HK1006024A1 (en) 1988-06-04 1998-06-11 Hirudin derivatives with delayed action

Country Status (21)

Country Link
US (1) US5538946A (xx)
EP (1) EP0345616B1 (xx)
JP (1) JP2804514B2 (xx)
KR (1) KR0140884B1 (xx)
AT (1) ATE130315T1 (xx)
AU (1) AU625215B2 (xx)
CA (1) CA1340197C (xx)
CY (1) CY2025A (xx)
DE (2) DE3819079A1 (xx)
DK (1) DK175103B1 (xx)
ES (1) ES2080732T3 (xx)
FI (1) FI98703C (xx)
GR (1) GR3018364T3 (xx)
HK (1) HK1006024A1 (xx)
HU (1) HU204851B (xx)
IE (1) IE72201B1 (xx)
IL (1) IL90507A0 (xx)
NO (1) NO177312C (xx)
NZ (1) NZ229402A (xx)
PT (1) PT90743B (xx)
ZA (1) ZA894180B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
US5663141A (en) * 1989-12-01 1997-09-02 Basf Aktiengesellschaft Hirudin/polyalkylene glycol conjugates and hirudin muteins
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン
GB2247239A (en) * 1990-08-22 1992-02-26 Ciba Geigy Ag Hirudin conjugates with polyoxyethylene
DE4041185A1 (de) * 1990-12-21 1992-06-25 Knoll Ag Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren
DE4437502A1 (de) * 1993-12-02 1995-06-08 Basf Ag Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19533817C2 (de) * 1995-09-13 1999-12-09 Max Planck Gesellschaft Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US5856452A (en) 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
US6809076B2 (en) * 2000-03-20 2004-10-26 Abbott Gmbh & Co. Kg Use of anticoagulant agents in the extracorporeal treatment of blood
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1979000638A1 (en) * 1978-02-17 1979-09-06 Thin Conductive Coating Oester A method of producing thrombosis-resistant surfaces
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
EP0158564B1 (fr) * 1984-03-27 1992-07-15 Transgene S.A. Vecteurs d'expression de l'hirudine, cellules transformées et procédé de préparation de l'hirudine
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens

Also Published As

Publication number Publication date
KR0140884B1 (ko) 1998-06-15
HU204851B (en) 1992-02-28
NO177312C (no) 1995-08-23
AU625215B2 (en) 1992-07-02
CY2025A (en) 1998-02-20
GR3018364T3 (en) 1996-03-31
DK270789D0 (da) 1989-06-02
IE891815L (en) 1989-12-04
HUT51298A (en) 1990-04-28
NO177312B (no) 1995-05-15
FI892686A0 (fi) 1989-06-01
DE58909493D1 (de) 1995-12-21
US5538946A (en) 1996-07-23
CA1340197C (en) 1998-12-15
NZ229402A (en) 1992-05-26
DE3819079A1 (de) 1989-12-07
DK270789A (da) 1989-12-05
EP0345616B1 (de) 1995-11-15
PT90743B (pt) 1994-10-31
ES2080732T3 (es) 1996-02-16
ATE130315T1 (de) 1995-12-15
JP2804514B2 (ja) 1998-09-30
ZA894180B (en) 1990-02-28
NO892267L (no) 1989-12-05
AU3595589A (en) 1989-12-07
EP0345616A2 (de) 1989-12-13
IE72201B1 (en) 1997-04-09
JPH0267300A (ja) 1990-03-07
FI98703C (fi) 1997-08-11
IL90507A0 (en) 1990-01-18
FI892686A (fi) 1989-12-05
KR910001041A (ko) 1991-01-30
EP0345616A3 (de) 1991-03-20
DK175103B1 (da) 2004-06-01
FI98703B (fi) 1997-04-30
PT90743A (pt) 1989-12-29
NO892267D0 (no) 1989-06-02

Similar Documents

Publication Publication Date Title
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
HK1006024A1 (en) Hirudin derivatives with delayed action
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
HU9203074D0 (en) 2-substituted indene-2-mercapto-acetamide being inhibitors of encefalinase and ace
HU9203075D0 (en) 2-substituted indene-2-carboxi-alkyl derivatives being inhibitors of encefalinase and ace
HUT40331A (en) Process for preparing pharmaceutical compositions containing a combination of dihidro-pyridines and ace-inhibitors
IL87542A0 (en) Arylenediamino substituted triazine derivatives,processes for the preparation thereof and compositions containing the same
GR3015634T3 (en) Process for the preparation of micronised biodegradable particles.
HU9200771D0 (en) Process for the production of aryl-1,2,4-triazolyn-5-on derivatives
EP0335409A3 (en) Pyrimidine derivatives, processes for their production and herbicidal compositions containing them
GB2243608B (en) Process for the preparation of 1,4-dihydro-pyridine derivatives
ES8505363A1 (es) Un procedimiento para preparar una 3-(2-furoil)-5-2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridina
IL101743A0 (en) 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
AU3682589A (en) Clasp for articles of jewellery such as chains, bracelets or similar
FR2582200B1 (fr) Fermoir notamment pour article de bijouterie tel que chaine, bracelet
HU882500D0 (en) Process for the preparation of pentaerythrityl-tetrakis-3-/3,4-di/tert-butyl/-4-oxy-phenyl/-propionate

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090529